Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
4’130 JPY | -0.19% | +0.02% | +1.87% |
16.05. | Takeda Kanada schließt LOI-Phase für Cytomegalovirus-Behandlung nach Transplantation ab | MT |
15.05. | Dengue-Impfstoff von Takeda Pharmaceutical erhält Präqualifikation der WHO | MT |
ETFs investiert in Takeda Pharmaceutical Company Limited
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
24,44% | 19 M€ | +11.32% | ||
5,00% | 288 M€ | +24.13% | ||
3,80% | 1 531 M€ | +20.49% | ||
3,43% | 240 M€ | +17.87% | ||
3,26% | 60 M€ | +22.66% | ||
1,68% | 14 M€ | +18.57% | ||
1,65% | 9 760 M€ | +17.51% | ||
1,65% | 4 929 M€ | +17.38% | ||
1,50% | 70 M€ | +16.92% | ||
1,50% | 0 M€ | 0.00% | - | |
1,38% | 17 M€ | +11.76% | - | |
1,38% | 63 295 M€ | +17.36% | - | |
1,38% | 20 360 M€ | +16.11% | - | |
1,38% | 140 441 M€ | +17.30% | ||
1,34% | 25 M€ | +17.60% | ||
0,79% | 5 M€ | -.--% | - | |
0,54% | 15 324 M€ | +15.88% | - | |
0,53% | 28 258 M€ | +16.92% | - | |
0,50% | 25 M€ | +5.10% | - | |
0,46% | 727 M€ | +9.36% | ||
0,44% | 4 M€ | +17.30% | ||
0,43% | 64 792 M€ | +16.79% | ||
0,35% | 36 M€ | +3.64% | - | |
0,27% | 10 M€ | -3.35% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+1.87% | 41.69 Mrd. | |
+32.09% | 693 Mrd. | |
+29.39% | 584 Mrd. | |
-1.34% | 372 Mrd. | |
+20.34% | 332 Mrd. | |
+7.39% | 294 Mrd. | |
+14.25% | 239 Mrd. | |
-3.03% | 211 Mrd. | |
+10.02% | 210 Mrd. | |
+8.49% | 168 Mrd. |
- Börse
- Aktien
- 853849 Aktie
- ETFs Takeda Pharmaceutical Company Limited